# Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation

> **NCT00597441** · PHASE1 · TERMINATED · sponsor: **Sumitomo Pharma Switzerland GmbH** · enrollment: 6 (actual)

## Conditions studied

- Stem Cell Transplantation

## Interventions

- **BIOLOGICAL:** Thymic Transplantation for Recipients of UCB transplant

## Key facts

- **NCT ID:** NCT00597441
- **Lead sponsor:** Sumitomo Pharma Switzerland GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-11
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** accrual of evaluable subjects too low
- **Last updated:** 2022-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00597441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00597441, "Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus Transplantation". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00597441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*